Food and Drug Administration

Blood Products Advisory Committee

June 14, 2002

Open Public Hearing

Cover Letter from BioTime, Inc. regarding Hextend ®  doc

Summary, BioTime, Inc.  doc

Hextend®, Abbott Labs  pdf

Letter from Dr. Aryeh Shander to Dr Linda Smallwood, MD, FDA regarding STORMACT  doc

Letter from Dr. Aryeh Shander, MD, Society for the Advancement of Blood Management  doc